Monoclonal Antibody Therapy (MAB) now at Hampton Regional

VARNVILLE, S.C. (September 28, 2021) – Hampton Regional Medical Center is now offering monoclonal antibody therapy (MAB) for treatment of COVID-19. In clinical trials of patients with COVID-19, MAB was shown to reduce COVID-19 related hospitalizations or emergency room visits in patients at high risk for disease progression. Monoclonal Antibody infusion therapy increases a person’s own immune response to the fight the COVID-19 virus.

MAB is available to individuals have a positive COVID-19 test, are 12 years of age or older (at least 88 pounds), and who are identified as high-risk for progressing to severe disease or hospitalization by meeting one of the following criteria:

  • Are 65 or older
  • Have a BMI greater than 35
  • Pregnancy
  • Chronic kidney disease
  • Diabetes
  • Are 12 to 17 and have a BMI at or above the 85th percentile or sickle cell disease, heart disease, neurodevelopmental disorders, or medical technology dependence (for example, tracheostomy, gastrostomy, or positive pressure ventilation)
  • Immunosuppressive disease and/or receiving immunosuppressive treatment
  • Cardiovascular disease (including congenital heart disease) or hypertension
  • Neurodevelopmental disorders
  • Sickle cell disease
  • Chronic lung diseases

Monoclonal Antibody therapy can benefit patients who meet the criteria and have a physician order. Hampton Regional Medical Center provides MAB in the infusion clinic located in the hospital. The treatment takes approximately an hour, followed by an hour of observation. If you have any questions, please contact the hospital at 803-943-2771.